期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 180, 期 10, 页码 1362-1378出版社
WILEY
DOI: 10.1111/bph.16020
关键词
chemotherapy; CPT-11; drug metabolism; gut microbiome; irinotecan; opioids
This study found that co-administration of opioids exacerbates chemotherapy-induced gastrointestinal toxicity, possibly due to gut microbial dysbiosis caused by opioids leading to increased production of beta-glucuronidase, which worsens the toxicity of the chemotherapy drug.
Background and PurposeOpioids are commonly used for the management of cancer-associated pain and chemotherapy-induced diarrhoea. The chemotherapeutic irinotecan (CPT-11) causes severe gastrointestinal (GI) toxicity due to deconjugation of inactive metabolite SN-38 glucuronide (SN-38G) by bacterial beta-glucuronidases to the active 7-ethyl-10-hydroxycamptothecin (SN-38). Opioids are known to cause gut microbial dysbiosis, this study evaluated whether CPT-11 anti-tumour efficacy and GI toxicity are exacerbated by opioid co-administration. Experimental ApproachEight-week-old C57BL/6 male mice were co-administration with CPT-11 +/- opioid. 16S rRNA sequencing was used for gut microbiome analysis. LC-MS analyses of plasma and intestinal extracts were performed to investigate the pharmacokinetic profile of CPT-11. Histological analysis and quantitative real-time polymerase chain reaction were used to determine the severity of intestinal tissue damage. Human liver microsome In vitro assay was performed to confirm the effects of opioids on CPT-11 metabolism. Key ResultsGut microbiome analysis showed that morphine treatment induced enrichment of beta-glucuronidase-producing bacteria in the intestines of CPT-11-treated mice, resulting in SN-38 accumulation and exacerbation of GI toxicity in the small intestine. Oral administration of both antibiotics and glucuronidase inhibitor protected mice against GI toxicity induced with CPT-11 and morphine co-administration, implicating a microbiome-dependent mechanism. Additionally, morphine and loperamide decreased the plasma concentration of SN-38 and compromised CPT-11 anti-tumour efficacy, this seemed to be microbiome independent. Conclusion and ImplicationsGut microbiota play a significant role in opioid and chemotherapeutic agent drug-drug interactions. Inhibition of gut microbial glucuronidase may also prevent adverse GI effects of CPT-11 in patients on opioids.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据